Multispecific Abs

Strategic Biomanufacturing Partner for Multispecific Antibodies

Jina Kim; Busol Park; Youngsun Kim

Samsung Biologics

Drug Approvals

How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?

Pharma's Almanac

RNA

What new opportunities are emerging for mRNA technology, and how is the portfolio of applications expanding beyond vaccines?

Pharma's Almanac

Formulation

Overcoming Challenges to High-Concentration Formulation Development

Heonchang Lim

Samsung Biologics

AI

Is AI truly transforming drug development, or are we still navigating through the hype?

Pharma's Almanac

Supply Chain

What strategies are ensuring supply chain resilience in a post-COVID world?

Pharma's Almanac

Sustainability

How can pharma manufacturing align with green initiatives while maintaining efficiency and compliance?

Pharma's Almanac

Biomanufacturing

Enabling Digital Twins With Computational Fluid Dynamics Modeling

Sangmin Paik, Ph.D.

Samsung Biologics

AI

AI Implementation to Enhance Quality

Seongil Cho; Hyeokgeon Kwon; Kisung Shim

Samsung Biologics

Lyophilization

Enhancing Biopharmaceutical Stability Through Lyophilization

David King; Hoju Lee; Sungjin Park; Yeonju Yoon

Samsung Biologics

Innovation

How is the pharmaceutical industry integrating innovations from adjacent industries to enhance drug development and production?

Pharma's Almanac

RNA

Optimized Residual dsRNA Detection for mRNA Therapeutics

Eunseo (Ency) Lee, Ph.D; Namhyun Kim; Hwanjun Yoon, Ph.D.; Sukhwan Kim; Ahyeon Hwang

Samsung Biologics

Developability

Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform

Heonchang Lim

Samsung Biologics

Sequence Variants

Accelerating Protein Sequence Variant Analysis

Kyoungmin Lee; Yunjeong Heo; Jongbae Park

Samsung Biologics